180 Degree Capital says combination is in ‘best interest of all’ shareholders
Degree Capital (TURN) issued a Q4 2024 Shareholder Letter, which read in part, “We are incredibly proud of our recent announcement of the ...
Tevogen Bio CEO Reinforces Commitment to Retention of Equity Capital and Long-Term Vision
“I’m not opposed to the concept of equity financing, I believe that preserving equity is fundamental to preserving a Founder’s vision,” said Ryan Saadi, Founder and CEO of Tevogen Bio. “From a ...